626
Participants
Start Date
December 31, 2009
Primary Completion Date
February 28, 2013
Study Completion Date
February 28, 2014
FCM (Ferric carboxymaltose) high ferritin target
FCM (Ferric carboxymaltose) low ferritin target
Oral Iron (Ferrous sulphate)
Karolinska University Hospital, Stockholm
Gosford Hospital - Renal Research, Gosford
Medizinische Universität Innsbruck Univ.-Klinik für Innere Medizin IV, Innsbruck
Lillebalt Frederica Sygehus Department of Nephrology, Frederica
St. Olav's Hospital, Trondheim
RHMS Baudour - Department of Nephrology and Dialysis, Baudour
Praxis Dr. Kraatz, Demmin
Trial Management Associates, Wilmington
CHU grenoble - Service de Nephrologie, Grenoble
Hospital Universitario Marqués de Valdecilla - Servicio de Nefrología, Santander
General Hospital of Arta - Nephrology Department, Arta
Nemocnice s poliklinikou v Novem Jicine, p.o. p.o. Interni oddeleni - nefrologie a dialyza, Nový Jičín
Ospedali Riuniti Anzio-Nettuno ASL ROMA H U.O. Nefrologia e Dialisi, Anzio
Meander Medisch Centrum - Locatie Amersfoort Lichtenberg, Amersfoort
Miedzyleski Szpital Spec. Oddzial I Wewnetrzny I Nefrologii, Warsaw
Hospital Santa Maria - Nefrologia, Lisbon
"Spitalul Clinic de NefrologieDr Carol Davila", Bucharest
Cukurova University Medical Faculty Balcali Hospital - Department of Nephrology, Adana
King's College Hospital, London
Lead Sponsor
Collaborators (2)
American Regent, Inc.
INDUSTRY
ICON Clinical Research
INDUSTRY
Vifor Pharma
INDUSTRY